Medical Cannabis Canada actively engages in public relations and government consultations to positively impact change on behalf of our patient membership. Specifically, MCC is (or has been) engaged in the following policy areas:
Links are provided for policy documents where applicable.
Federal Policy (Active Files)
- Taxation (zero-rating of medical cannabis)
- Bill C-74 FINA Committee Coalition Submission (May 9, 2018)
- DontTaxMedicine.ca campaign (Started Nov. 2017)
- Finance Canada Consultation Submission Coalition (Dec. 7, 2017)
- Bill C-45 (Cannabis Act/legalization)
- Bill C-46 (Impaired Driving)
- Research Funding
- Legalization Task Force Consultations
- Access to Cannabis for Medical Purposes Regulations (ACMPR)
- Affordability (zero-rating)
- Access (including distribution)
- Switching between LPs
- Safety (including pesticide use)
- Registration and documentation (LP and personal production)
- Education
Provincial/Territory Policy (Active Files)
- Legalization (provincial/territory roles)
- Alberta (public consultation submission)
- British Columbia
- Manitoba
- New Brunswick (public consultation submission)
- Newfoundland and Labrador
- Northwest Territories
- Nova Scotia
- Nunavut
- Ontario (public consultation submission)
- PEI
- Quebec
- Saskatchewan
- Yukon
- Public formulary coverage (multiple provinces and plans)
Previous Policy Areas (Inactive Files)
- CATSA medical cannabis screening policy – Canadian Air Transport Security Authority Act
- Successful -policy was updated and CATSA no more conducts mandatory police screening
- Complaint to Privacy Commissioner of Canada (ongoing)
- Ontario Bill 45, Making Healthier Choices Act (May 2015)
- Ontario Bill 178, Smoke Free Ontario Act Amendment (Winter/Spring 2016)